Effect of DC-CIK cells combined with oridonin on cytotoxicity against RPMI 8226 cells
10.3969/j.issn.1006-5725.2014.14.007
- VernacularTitle:冬凌草甲素联合DC-CIK细胞杀伤RPMI 8226细胞的研究
- Author:
Jia QU
;
Yu ZHAN
;
Kexin FENG
;
Lingzhen CHEN
;
Jinming WU
;
Yuqing YANG
- Publication Type:Journal Article
- Keywords:
Oridonin;
DC-CIK;
Multiple myeloma;
NKG2D-NKG2DL
- From:
The Journal of Practical Medicine
2014;(14):2208-2210
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes in cytotoxicity of DC-CIK cells to human multiple myeloma RPMI 8226 cells before and after treatment with oridonin. Methods Normal human peripheral blood mononuclear cells were isolated and induced to obtain DC-CIK cells. Cytotoxicity of DC-CIK cells against RPMI 8226 cells which were treated by oridonin was analyzed by LDH releasing assay. The variation for expression of NKG2D ligands on RPMI 8226 cells were measured by flow cytometry. Results DC-CIK cells were successfully induced from the peripheral blood mononuclear cells. At the same effector to target ratio, oridonin obviously enhanced the cytotocixity of DC-CIK cells against RPMI 8226 cells (P<0.01). Flow cytometry showed the expression of NKG2D ligands ULBP1 of RPMI8226 cells was most significantly increased as the cells were treated by oridonin [(9.19 ± 1.85) vs. (15.47 ± 0.67), P<0.01]. Correlation analysis indicated that cytotocixity was positively correlated with changes in ULBP1. Conclusions Oridonin can improve the cytotoxicity of DC-CIK cells against RPMI 8226 cells, which may be related with the increased expressions of NKG2D ligands on the tumor cell surface.
